The [Continuous Bioprocessing Market] is undergoing a significant transformation, driven by the biopharmaceutical industry's urgent need for greater efficiency, flexibility, and cost-effectiveness in manufacturing. Valued at approximately USD 8.85 billion in 2024, the market is projected to reach USD 19.32 billion by 2035, growing at a compound annual growth rate (CAGR) of 7.36%,...
English
Arabic
French
Spanish
Portuguese
Turkish
Dutch
Italiano
Russian
Romaian
Portuguese (Brazil)
Greek